In the latter work, Sandsmark et al. reported higher immunohistochemistry staining levels of SFRP4 in prostate cancer samples as compared to normal samples, and also found that four out of five mRNA expression studies, which included both normal and cancer tissues, observed SFRP4 up regulation in the tumor samples [19]. The gene discussed is SFRP4; the disease is cancer.